A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMPX SEC filings page.
Amprius Technologies, Inc. (AMPX) reported $109.2M in revenue over the twelve months to Jun 30, 2026, up 143.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue reached $73.0M in FY2025, but gross profitability arrived before operating breakeven as fixed operating costs remained heavy.
Gross margin swung from-75.9% in FY2024 to11.3% in FY2025, a change in reported gross economics beyond topline expansion. Yet operating margin remained-63.9% , showing the new gross profit is still consumed by operating infrastructure and development spending rather than reaching the bottom line.
Gross profit reached
Financing cash flow supplied
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Amprius Technologies, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Amprius Technologies, Inc. held $90.5M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $31.1M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Amprius Technologies, Inc. scores 59/100 among other emerging companies.
Amprius Technologies, Inc. had 137M shares outstanding at the end of fiscal year 2025, against 118M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Amprius Technologies, Inc. scores 34/100 among other emerging companies.
Amprius Technologies, Inc. spent $9.4M on research and development in fiscal year 2025, which was 7.9% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Amprius Technologies, Inc. scores 31/100 among other emerging companies.
Amprius Technologies, Inc. reported revenue of $73.0M in fiscal year 2025, against $24.2M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Amprius Technologies, Inc. scores 90/100 among other emerging companies.
Amprius Technologies, Inc.'s operations used $31.1M of cash in fiscal year 2025, against $33.4M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Amprius Technologies, Inc. scores 35/100 among other emerging companies.
Amprius Technologies, Inc.'s cash, cash equivalents and investments came to $90.5M at the end of fiscal year 2025, against $53.1M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Amprius Technologies, Inc. scores 71/100 among other emerging companies.
Amprius Technologies, Inc. scores 13.87, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.4B) relative to total liabilities ($53.1M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Amprius Technologies, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Amprius Technologies, Inc. reported a net loss of $44.0M while operations used $31.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Amprius Technologies, Inc. generated $34.0M in revenue in Q2 2026. This represents an increase of 125.9% from the same quarter a year earlier. Against the prior quarter it is up 19.3%.
Amprius Technologies, Inc.'s EBITDA was -$3.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 38.8% from the same quarter a year earlier. Against the prior quarter it is up 41.0%.
Amprius Technologies, Inc. reported -$3.2M in net income in Q2 2026. This represents an increase of 50.5% from the same quarter a year earlier. Against the prior quarter it is up 37.5%.
Cash & Balance Sheet
Amprius Technologies, Inc. recorded an outflow of $4.7M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 6.2% from the same quarter a year earlier. Against the prior quarter it is up 87.8%.
Amprius Technologies, Inc. held $74.5M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Amprius Technologies, Inc.'s gross margin was 27.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 18.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.2 percentage points.
Amprius Technologies, Inc.'s operating margin was -12.6% in Q2 2026, reflecting core business profitability. This is up 32.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.8 percentage points.
Amprius Technologies, Inc.'s net profit margin was -9.3% in Q2 2026, showing the share of revenue converted to profit. This is up 33.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.4 percentage points.
Amprius Technologies, Inc.'s ROE was -2.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 5.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.1 percentage points.
Capital Allocation
Amprius Technologies, Inc. invested $4.1M in research and development in Q2 2026. This represents an increase of 89.6% from the same quarter a year earlier. Against the prior quarter it is up 7.9%.
Amprius Technologies, Inc. invested $1.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 154.1% from the same quarter a year earlier. Against the prior quarter it is up 85.6%.
Not reported for Q2 2026.
AMPX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.0M+125.9% | $28.5M+152.9% | $25.2M+137.4% | $21.4M+172.8% | $15.1M+350.4% | $11.3M+383.0% | $10.6M+169.5% | $7.9M+180.7% |
| Cost of Revenue | $24.8M+80.3% | $22.8M+67.1% | $19.3M+49.5% | $18.1M+39.8% | $13.7M+39.0% | $13.6M+101.2% | $12.9M+64.7% | $13.0M+83.9% |
| Gross Profit | $9.3M+592.5% | $5.7M+343.1% | $6.0M+364.8% | $3.3M+165.0% | $1.3M+120.5% | -$2.4M+46.9% | -$2.3M+41.9% | -$5.1M-20.1% |
| R&D Expenses | $4.1M+89.6% | $3.8M+89.7% | $2.8M+20.7% | $2.5M+38.1% | $2.2M+30.1% | $2.0M+26.7% | $2.3M+77.1% | $1.8M+122.9% |
| SG&A Expenses | $9.5M+58.2% | $8.6M+62.6% | $6.2M+14.9% | $5.5M+26.9% | $6.0M+26.4% | $5.3M+23.6% | $5.4M+17.1% | $4.3M+6.6% |
| Operating Income | -$4.3M+36.9% | -$6.7M+30.9% | -$25.5M-116.6% | -$4.7M+58.3% | -$6.8M+47.3% | -$9.7M+6.3% | -$11.8M-20.7% | -$11.3M-23.2% |
| EBITDA | -$3.5M+38.8% | -$5.9M+32.1% | -$24.3M-124.0% | -$3.5M+66.6% | -$5.7M+51.7% | -$8.7M+6.2% | -$10.9M-17.4% | -$10.5M-19.7% |
| Income Tax | N/A | $0 | N/A | N/A | N/A | $0 | N/A | N/A |
| Net Income | -$3.2M+50.5% | -$5.0M+46.2% | -$24.4M-113.6% | -$3.9M+64.1% | -$6.4M+49.1% | -$9.4M+5.2% | -$11.4M-17.3% | -$10.8M-27.8% |
| EPS (Basic) | -$0.04+20.0% | -$0.04+50.0% | -$0.19-72.7% | -$0.03+70.0% | -$0.05+61.5% | -$0.08+27.3% | -$0.110.0% | -$0.100.0% |
| EPS (Diluted) | -$0.04 | -$0.04+50.0% | -$0.19-72.7% | -$0.03+70.0% | -$0.05+61.5% | -$0.08+27.3% | -$0.110.0% | -$0.100.0% |
| Diluted Shares (Avg) | 143M | 137M+16.1% | N/A | 127M+14.7% | 122M+25.5% | 118M+31.0% | N/A | 110M+27.9% |
Not reported in any period shown, so not listed: Interest Expense.
AMPX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $149.2M+21.2% | $130.8M+10.4% | $156.9M+29.5% | $156.5M+50.2% | $123.0M+9.1% | $118.5M+13.2% | $121.1M+12.4% | $104.2M+20.3% |
| Current Assets | $131.6M+83.1% | $114.0M+72.3% | $126.4M+83.9% | $106.7M+137.4% | $71.9M+35.5% | $66.1M+44.9% | $68.8M+36.1% | $44.9M-26.8% |
| Cash & Equivalents | $74.5M+37.5% | $62.4M+28.8% | $90.5M+64.0% | $73.2M+108.9% | $54.2M+16.7% | $48.4M+24.0% | $55.2M+20.5% | $35.0M-34.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $11.5M+165.5% | $8.2M+106.0% | $6.7M+2.4% | $4.7M+75.6% | $4.3M+183.9% | $4.0M+366.6% | $6.6M+800.5% | $2.7M+447.0% |
| Accounts Receivable | $40.6M+277.6% | $35.3M+239.2% | $23.7M+323.9% | $21.9M+377.5% | $10.8M+519.4% | $10.4M+620.9% | $5.6M+330.8% | $4.6M+143.2% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $23.5M-49.2% | $21.4M-55.5% | $53.1M+2.8% | $53.3M+10.5% | $46.4M-2.6% | $48.1M+7.4% | $51.7M+7.8% | $48.2M+131.1% |
| Current Liabilities | $18.4M+51.9% | $16.0M+14.5% | $17.9M+3.8% | $16.1M+23.5% | $12.1M-5.8% | $14.0M+43.0% | $17.2M+27.9% | $13.0M-6.3% |
| Non-Current Liabilities | $5.2M-84.9% | $5.4M-84.2% | $35.2M+2.2% | $37.2M+5.7% | $34.3M-1.4% | $34.1M-2.5% | $34.4M-0.1% | $35.2M+404.1% |
| Total Equity | $125.6M+63.9% | $109.4M+55.4% | $103.8M+49.4% | $103.2M+84.3% | $76.7M+17.7% | $70.4M+17.5% | $69.5M+16.2% | $56.0M-14.8% |
| Retained Earnings | -$226.6M-19.2% | -$223.4M-21.6% | -$218.4M-25.3% | -$194.0M-19.1% | -$190.1M-25.0% | -$183.7M-31.6% | -$174.3M-34.5% | -$162.9M-35.8% |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
AMPX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$2.9M+33.2% | -$37.3M-163.9% | -$3.5M+42.5% | -$9.2M+3.0% | -$4.3M+46.4% | -$14.1M-44.5% | -$6.1M-26.8% | -$9.5M-9.8% |
| Depreciation & Amortization | $800K-27.3% | $761K-19.3% | $1.2M+37.4% | $1.2M+50.0% | $1.1M0.0% | $943K-7.3% | $891K+82.6% | $800K+100.0% |
| Stock-Based Compensation | $2.5M+33.3% | $2.1M+13.0% | N/A | $1.8M+2.5% | $1.9M-1.8% | $1.8M+46.1% | N/A | $1.7M+54.3% |
| Capital Expenditures | $1.8M+154.1% | $980K+7.3% | $2.4M-35.0% | $414K-68.9% | $716K-55.4% | $913K-76.6% | -$3.6M-36.9% | $1.3M-85.1% |
| Free Cash Flow | -$4.7M+6.2% | -$38.3M-154.4% | -$5.9M+39.7% | -$9.7M+11.1% | -$5.0M+47.9% | -$15.0M-10.0% | -$9.7M+8.0% | -$10.9M+38.3% |
| Investing Cash Flow | -$1.8M-154.1% | -$625K+31.5% | -$2.4M-165.0% | -$414K+68.9% | -$716K+55.4% | -$913K+76.6% | $3.6M+163.1% | -$1.3M+85.1% |
| Financing Cash Flow | $16.8M+56.4% | $8.6M+0.9% | $23.1M+2.3% | $28.7M+5413.1% | $10.8M-36.6% | $8.5M+4.2% | $22.6M+673.9% | -$540K-109.0% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AMPX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.3%+18.4pp | 20.1%+41.0pp | 23.6%+44.8pp | 15.5%+80.4pp | 8.9% | -20.9% | -21.2%+77.2pp | -64.9% |
| Operating Margin | -12.6%+32.6pp | -23.4%+62.3pp | -100.9% | -21.9% | -45.2% | -85.7% | -110.6% | -143.3% |
| Net Margin | -9.3%+33.0pp | -17.7%+65.4pp | -96.7% | -18.2% | -42.3% | -83.0% | -107.4% | -138.1% |
| Return on Equity | -2.5%+5.8pp | -4.6%+8.7pp | -23.5%-7.1pp | -3.8%+15.6pp | -8.3%+10.9pp | -13.3%+3.2pp | -16.4%-0.2pp | -19.4%-6.5pp |
| Return on Assets | -2.1%+3.1pp | -3.9%+4.0pp | -15.6%-6.1pp | -2.5%+7.9pp | -5.2%+5.9pp | -7.9%+1.5pp | -9.4%-0.4pp | -10.4%-0.6pp |
| Current Ratio | 7.17+1.2x | 7.13+2.4x | 7.08+3.1x | 6.65+3.2x | 5.95+1.8x | 4.74+0.1x | 4.00+0.2x | 3.46-1.0x |
| Debt-to-Equity | 0.19-0.4x | 0.20-0.5x | 0.51-0.2x | 0.52-0.3x | 0.61-0.1x | 0.68-0.1x | 0.74-0.1x | 0.86+0.5x |
| Asset Turnover | 0.23+0.1x | 0.22+0.1x | 0.16+0.1x | 0.14+0.1x | 0.12+0.1x | 0.10+0.1x | 0.09+0.1x | 0.080.0x |
| FCF Margin | -13.7%+19.3pp | -134.1% | -23.2%+68.2pp | -45.1% | -33.1% | -133.3% | -91.4% | -138.3% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Amprius Technologies, Inc. AMPX | FY2025 | $73.0M | -$44.0M | -60.3% | $1.4B | 53/100 |
| Preformed Line Products Co PLPC | FY2025 | $669.3M | $35.3M | 5.3% | $2.0B | 68/100 |
| Kimball Electronics, Inc. KE | FY2026 | $1.4B | $28.0M | 1.9% | $697.4M | 50/100 |
| ADS-TEC ENERGY PLC ADSE | FY2023 | N/A | N/A | N/A | $728.6M | — |
| Energizer Holdings, Inc ENR | FY2025 | $3.0B | $239.0M | 8.1% | $1.5B | 25/100 |
| Lightbridge Corp. LTBR | FY2025 | $0 | -$19.6M | N/A | $226.2M | — |
Where Amprius Technologies, Inc. Ranks
Frequently Asked Questions
What is Amprius Technologies, Inc.'s annual revenue?
Amprius Technologies, Inc. (AMPX) reported $73.0M in total revenue for fiscal year 2025. This represents a 202.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Amprius Technologies, Inc.'s revenue growing?
Amprius Technologies, Inc. (AMPX) revenue grew by 202.1% year-over-year, from $24.2M to $73.0M in fiscal year 2025.
Is Amprius Technologies, Inc. profitable?
No, Amprius Technologies, Inc. (AMPX) reported a net income of -$44.0M in fiscal year 2025, with a net profit margin of -60.3%.
What is Amprius Technologies, Inc.'s EBITDA?
Amprius Technologies, Inc. (AMPX) had EBITDA of -$42.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Amprius Technologies, Inc.'s gross margin?
Amprius Technologies, Inc. (AMPX) had a gross margin of 11.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Amprius Technologies, Inc.'s operating margin?
Amprius Technologies, Inc. (AMPX) had an operating margin of -63.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Amprius Technologies, Inc.'s net profit margin?
Amprius Technologies, Inc. (AMPX) had a net profit margin of -60.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Amprius Technologies, Inc.'s return on equity (ROE)?
Amprius Technologies, Inc. (AMPX) has a return on equity of -42.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Amprius Technologies, Inc.'s free cash flow?
Amprius Technologies, Inc. (AMPX) recorded an outflow of $35.5M in free cash flow during fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Amprius Technologies, Inc.'s operating cash flow?
Amprius Technologies, Inc. (AMPX) recorded an outflow of $31.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Amprius Technologies, Inc.'s total assets?
Amprius Technologies, Inc. (AMPX) had $156.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Amprius Technologies, Inc.'s capital expenditures?
Amprius Technologies, Inc. (AMPX) invested $4.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Amprius Technologies, Inc. spend on research and development?
Amprius Technologies, Inc. (AMPX) invested $9.4M in research and development during fiscal year 2025.
What is Amprius Technologies, Inc.'s current ratio?
Amprius Technologies, Inc. (AMPX) had a current ratio of 7.08 as of fiscal year 2025, which is generally considered healthy.
What is Amprius Technologies, Inc.'s debt-to-equity ratio?
Amprius Technologies, Inc. (AMPX) had a debt-to-equity ratio of 0.51 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Amprius Technologies, Inc.'s return on assets (ROA)?
Amprius Technologies, Inc. (AMPX) had a return on assets of -28.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Amprius Technologies, Inc.'s P/E ratio?
Amprius Technologies, Inc. (AMPX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.4B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Amprius Technologies, Inc.'s price-to-sales ratio?
Amprius Technologies, Inc. (AMPX) trades at 12.6x sales, its market capitalization divided by revenue of $109.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Amprius Technologies, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Amprius Technologies, Inc. (AMPX) held $90.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $31.1M over that year. Dividing the one by the other, the reported balance equals about 35 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Amprius Technologies, Inc.'s Altman Z-Score?
Amprius Technologies, Inc. (AMPX) has an Altman Z-Score of 13.87, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Amprius Technologies, Inc.'s Piotroski F-Score?
Amprius Technologies, Inc. (AMPX) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Amprius Technologies, Inc.'s earnings high quality?
Amprius Technologies, Inc. (AMPX) reported a net loss of $44.0M while operations used $31.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Amprius Technologies, Inc.?
Amprius Technologies, Inc. (AMPX) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.